234 related articles for article (PubMed ID: 26850565)
1. Contrast-enhancement ratio on multiphase enhanced computed tomography predicts recurrence of pancreatic neuroendocrine tumor after curative resection.
Arai T; Kobayashi A; Fujinaga Y; Yokoyama T; Shimizu A; Motoyama H; Kitagawa N; Notake T; Shirota T; Fukushima K; Masuo H; Kadoya M; Miyagawa S
Pancreatology; 2016; 16(3):397-402. PubMed ID: 26850565
[TBL] [Abstract][Full Text] [Related]
2. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
[TBL] [Abstract][Full Text] [Related]
5. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
Canellas R; Burk KS; Parakh A; Sahani DV
AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Sichinohe T
Hepatogastroenterology; 2012; 59(120):2623-6. PubMed ID: 22497945
[TBL] [Abstract][Full Text] [Related]
8. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.
Nanno Y; Matsumoto I; Zen Y; Otani K; Uemura J; Toyama H; Asari S; Goto T; Ajiki T; Okano K; Suzuki Y; Takeyama Y; Fukumoto T; Ku Y
Ann Surg Oncol; 2017 Apr; 24(4):1127-1133. PubMed ID: 27822631
[TBL] [Abstract][Full Text] [Related]
10. Shape and Enhancement Characteristics of Pancreatic Neuroendocrine Tumor on Preoperative Contrast-enhanced Computed Tomography May be Prognostic Indicators.
Okabe H; Hashimoto D; Chikamoto A; Yoshida M; Taki K; Arima K; Imai K; Tamura Y; Ikeda O; Ishiko T; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Yamashita YI; Yoshizumi T; Beppu T; Yamashita Y; Baba H; Maehara Y
Ann Surg Oncol; 2017 May; 24(5):1399-1405. PubMed ID: 27896509
[TBL] [Abstract][Full Text] [Related]
11. Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
Iorgulescu DG; Ling S; Nikfarjam M; Fink MA; Jones R; Muralidharan V; Starkey G; Christophi C
ANZ J Surg; 2015 Apr; 85(4):270-3. PubMed ID: 24712309
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
13. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
[TBL] [Abstract][Full Text] [Related]
14. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
[TBL] [Abstract][Full Text] [Related]
15. Analysis of recurrence after the resection of pancreatic neuroendocrine tumors.
Chouliaras K; Newman NA; Shukla M; Swett KR; Levine EA; Sham J; Mann GN; Shen P
J Surg Oncol; 2018 Sep; 118(3):416-421. PubMed ID: 30259518
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
17. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.
Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE
J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Scoring System for the Prediction of Metastatic Recurrence Following Curative Resection of Pancreatic Neuroendocrine Tumors.
Sho S; Court CM; Winograd P; Toste PA; Pisegna JR; Lewis M; Donahue TR; Hines OJ; Reber HA; Dawson DW; Tomlinson JS
J Gastrointest Surg; 2019 Jul; 23(7):1392-1400. PubMed ID: 30353489
[TBL] [Abstract][Full Text] [Related]
19. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography.
Yamada S; Fujii T; Suzuki K; Inokawa Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2016 Feb; 45(2):198-203. PubMed ID: 26390421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]